North America Immune Repertoire Sequencing Market Size & Outlook

Name: North America Immune Repertoire Sequencing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The immune repertoire sequencing market in North America is expected to reach a projected revenue of US$ 378.1 million by 2033. A compound annual growth rate of 11.9% is expected of North America immune repertoire sequencing market from 2025 to 2033.

Biotechnology
- Sequencing technology
  - Immune Repertoire Sequencing Market Outlook

North America immune repertoire sequencing product & service outlook (Revenue, USD million, 2021-2033)
- Instruments
- Assay Kits & Reagents
  - TCR kits
  - BCR kits
  - Others
- Services
North America immune repertoire sequencing type outlook (Revenue, USD million, 2021-2033)
- Bulk immune repertoire sequencing
- Single cell immune repertoire sequencing
North America immune repertoire sequencing application outlook (Revenue, USD million, 2021-2033)
- Oncology & Cancer Immunotherapy
- Autoimmune & Inflammatory Diseases
- Infectious Diseases & Vaccine Development
- Transplantation & Immune Tolerance
- Others
North America immune repertoire sequencing end use outlook (Revenue, USD million, 2021-2033)
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others

North America Immune Repertoire Sequencing Market Size & Outlook

Data Tree

Sign up - it's easy, and free!